- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01333254
A Trial of Different Methods for Bladder Drainage in Hip Surgery Patients
October 4, 2016 updated by: Maria Halleberg Nyman, Region Örebro County
A Randomised Controlled Trial Comparing Different Methods for Short-Term Bladder Drainage in Patients With Hip Surgery
The aim of the project is to evaluate differences between intermittent and indwelling catheterisation in patients with hip surgery.
Specific objectives are to determine whether:
- frequencies of urinary tract problems in hospital and up to one year after discharge differ between patient groups treated with intermittent and indwelling catheterisation respectively.
- costs and health-effects differ between the patient groups.
- experiences of urinary catheterisation differ between the patient groups
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
170
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Örebro, Sweden, SE-70185
- Dept of Orthopaedic Surgery at Örebro University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients undergoing hip fracture surgery or hip replacement due to arthrosis
- Age 50 years and above
Exclusion Criteria:
- Patients with an indwelling catheter in situ
- Cognitive impairment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Indwelling urinary catheter
Patients in this group with hip fracture will get an indwelling catheter at arrival to the orthopaedic ward.
The patients with arthrosis get the indwelling catheter in the morning at the day of surgery.
In both cases the indwelling catheter is inserted after shower with skin disinfectant.
The catheter system is kept close.
The catheter will be removed in the morning on day 2 after surgery.
The patients are bladder-scanned every four-hour until normal bladder function is recaptured.
If the bladder volume exceeds 400ml and the patient is unable to urinate, the patient will be re-catheterised.
The procedure of the patients in this arm is in accordance with common practice in the Orthopaedic clinic.
|
|
Experimental: Intermittent urinary catheterisation
Patients randomised to this arm will urinate either in a toilet or in a bedpan or a diaper when needed.
Bladder scan control will be performed on these patients at least every four hour.
If the patient is unable to urinate and bladder scan indicates ≥ 400 ml urine in the bladder, the patient will be intermittent catheterised.
|
Patients randomised to the I group will urinate either in a toilet or in a bedpan or a diaper when needed.
Bladder scan control will be performed on these patients at least every four hour.
If the patient is unable to urinate and bladder scan indicates ≥ 450 ml urine in the bladder, the patient will be intermittent catheterised.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Nosocomial urinary tract infection
Time Frame: Urine culture will be collected at admission and before discharge from the orthopaedic ward (about 5-10 days after admission)
|
Urine culture will be collected at admission and before discharge from the orthopaedic ward (about 5-10 days after admission)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time to normal bladder function
Time Frame: Hours after surgery (participants will be followed for the duration of hospital stay, about 5-10 days)
|
Normal bladder function was in this study defined as a post-micturition residual urine volume of 150ml or less.The patients will be bladder-scanned every fourth hour until normal bladder function is recaptured
|
Hours after surgery (participants will be followed for the duration of hospital stay, about 5-10 days)
|
Costs for material and labour related to urinary catheterisation and nosocomial UTI during the first year after hip surgery
Time Frame: During time in hospital and up to 1 year after discharge
|
Costs will be considered for material and labour.
The material costs include costs for catheters, material used when inserting catheters, material used when using the bladder scan, costs for clothes and bedding changed due to urine and diapers.
Also costs for medication due to urinary problems will be registered.
The labour costs included are time for urinary catheterisation, bladder scan, change of patients' clothes and bedding or diapers due to urine, consultation at the Urological department or to a general practitioner due to urinary problems and length of hospital stay.
|
During time in hospital and up to 1 year after discharge
|
Health effects during the first year after hip surgery
Time Frame: Before discharge, 4 weeks, 4 months and 1 year after discharge
|
The health-effects will be evaluated by EQ5D and SF-36 at discharge, 4 weeks, 4 months and 1 year after discharge.
|
Before discharge, 4 weeks, 4 months and 1 year after discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Maria Hälleberg Nyman, RN, MSc, Örebro University Hospital, Sweden
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
April 1, 2011
First Submitted That Met QC Criteria
April 8, 2011
First Posted (Estimate)
April 11, 2011
Study Record Updates
Last Update Posted (Estimate)
October 5, 2016
Last Update Submitted That Met QC Criteria
October 4, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2009-075
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Tract Infections
-
GlaxoSmithKlineCompletedInfections, Urinary TractEgypt
-
University of WashingtonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Iterum Therapeutics, International LimitedCompletedComplicated Urinary Tract InfectionsUnited States, Estonia, Hungary, Georgia, Latvia
-
Shandong Branden Med.Device Co.,LtdTerminatedUrinary Tract Infection | Urinary CathetersChina
-
Inmunotek S.L.CompletedUrinary Tract Infection BacterialSpain, United Kingdom
-
Newcastle-upon-Tyne Hospitals NHS TrustCambridge University Hospitals NHS Foundation Trust; University of Southampton and other collaboratorsCompletedUrinary Tract Infections, RecurrentUnited Kingdom
-
Hospital del Río HortegaCompletedUrinary Tract Infection
-
Assaf-Harofeh Medical CenterNanovibronixUnknown
-
Bergaliden BarnavårdscentralCompleted
-
AbbottCompletedUrinary Tract Infections (UTIs)Pakistan
Clinical Trials on Intermittent urinary catheterisation
-
ConvaTec Inc.RecruitingMultiple Sclerosis | Lower Urinary Tract Symptoms | Parkinson Disease | Spinal Cord Injuries | Bladder Outlet Obstruction | Cauda Equina Syndrome | Detrusor Underactivity | Enlarged Prostate With Lower Urinary Tract SymptomsUnited States, United Kingdom, France
-
ConvaTec Inc.RecruitingNeurogenic BladderUnited Kingdom
-
St. Petersburg State Pavlov Medical UniversityRecruiting
-
Coloplast A/SWithdrawnSpinal Cord InjuryDenmark
-
St George Hospital, AustraliaCompletedUrinary RetentionAustralia
-
Assaf-Harofeh Medical CenterUnknown
-
Imperial College LondonUnknown
-
University of PisaCompletedSuccess Rate for Subclavian or Femoral Vein CatetherisationItaly
-
Marco ValgimigliCompleted
-
University Hospital, LilleInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedType 1 Diabetes | Organ Transplantation | ImmunosuppressionFrance